市场调查报告书
商品编码
1452957
全球基因表现分析市场 2024-2031Global Gene Expression Analysis Market 2024-2031 |
预计在预测期内(2024-2031 年),全球基因表现分析市场将以 8.6% 的复合CAGR成长。基因组研究的不断进步、慢性疾病盛行率的增加以及对基因表现分析工具的需求不断增长是推动全球市场的主要因素。
市场动态
Global Gene Expression Analysis Market Size, Share & Trends Analysis Report By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and Microarray), by Product (Instruments, Reagents & Consumables, and Services), By End-User (Drug Discovery and Development, Diagnostic Laboratories, and Academic Research Centers) Forecast Period (2024-2031)
Global gene expression analysis market is anticipated to grow at a considerable CAGR of 8.6% during the forecast period (2024-2031). The increasing advancements in genomic research, increasing prevalence of chronic disorders, and growing demand for gene expression analysis tools are major factors driving the global market.
Market Dynamics
Growing Focus of Researchers on Single-Cell Genomics
The growing interest of researchers in single-cell genomics is a key contributor to the market growth. As per the research published by the National Library of Medicine in March 2023, single-cell genomics is found to have numerous applications in the field of cardiovascular disorder research. It can be utilized in heart development, myocardial infarction, cardiac ischemia-reperfusion injury, atherosclerosis, atrial fibrillation, cardiac hypertrophy, and heart failure.
Increasing Demand for Personalized Medicine
The growing demand for novel drug discovery to minimize the growing incidence of cancers and other chronic disorders globally is another contributor to the industry's growth. Additionally, numerous collaborations among researchers and market players are also aiding the market growth. For instance, in February 2022, Genomic Medicine Sweden (GMS) and the Centers for Personalized Medicine (ZPM) in Germany, collaborated for strategic, structural, and content-specific efforts to implement precision medicine in healthcare.
Market Segmentation
NGS to Exhibit Highest CAGR During the Forecast Period
Based on the technology, the global gene expression analysis market is sub-segmented into Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), and microarray. The increasing use of NGS technology in clinical diagnosis owing to its high speed and efficiency at economic cost is a key contributor to the growth of this market segment. The increasing use of NGS technology in several applications including biomarker discovery, oncology studies, and personalized medicine is further aiding its market growth. Next-generation sequencing is used as a cancer diagnostic tool for analyzing genome sequences in cancer. The technique uses several technologies for the diagnosis of cancer, including protein microarrays, DNA microarrays, next-generation sequencing, and lab-on-a-chip & reverse transcriptase-PCR (RT-PCR), among others.
According to the Centers for Disease Control, 2021, it is projected that more than 60 million people will have their genomes sequenced by 2025 worldwide as countries have taken the initiative to sequence large populations. The existence of several initiatives of universities, academic and research institutions, and research establishments to use NGS to diagnose diseases is further aiding the market growth.
The global gene expression analysis market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).
Expansion of Genome sequencing across Asia-Pacific
The growing expansion of genome sequencing owing to increasing investment in this field across Asia-Pacific is a contributor to the high growth rate of the regional market.
North America Holds Major Market Share
Among all the regions, North America holds a significant share owing to the growing regional focus on clinical research. The US is home to several major biopharmaceutical companies such as Abbott Laboratories, Pfizer, Johnson & Johnson, and Novartis among others which are further contributing to the demand for gene expression analysis products. Moreover, the increasing demand for personalized medicine for companion diagnostics drives the growth of the regional market.
The major companies serving the global gene expression analysis market include Quest Diagnostics Inc., Illumina, Inc., PerkinElmer Inc., Agilent Technologies Inc., and Promega Corp. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as increasing investment, collaborations, mergers, and acquisitions to stay competitive in the market. For instance, in February 2024, 10x Genomics, Inc. launched GEM-X, the next generation of the company's single-cell technology. This will support researchers to drive better, faster, and more cost-effective single-cell research and enable more academic and translational researchers to routinely rely on these tools to help resolve biology's complexity.